The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects
Koufen, H.; Consbruch, U.
Der Nervenarzt 41(12): 599-603
1970
ISSN/ISBN: 0028-2804 PMID: 4924032 Document Number: 29613
Document emailed within 1 workday
Related Documents
Niebrój-Dobosz, I.; Domitrz, I.; Mickielewicz, A. 1999: Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase Folia Neuropathologica 37(2): 107-112Zatz, M.; Frota-Pessoa, O.; Levy, J.A.; Peres, C.A. 1976: Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study Journal de Genetique Humaine 24(2): 153-168
Pradat, P-F.; Bruneteau, G. 2006: Differential diagnosis and atypical subsets of amyotrophic lateral sclerosis Revue Neurologique (Paris) 162(Special Issue 2): 4s81-4s90
Lehmann, J. 1978: Clinical and pathological aspects of amyotrophic lateral sclerosis Neuropatologia Polska 16(1): 127-133
Zavalishin, I.A.; Khokhlov, A.P.; Larskiĭ, E.G.; Seĭfulla, R.D.; Roĭkhel', V.M. 1988: Biochemical aspects of the pathogenesis of amyotrophic lateral sclerosis Vestnik Akademii Meditsinskikh Nauk SSSR 12: 49-56
Bromberg, M.B. 2002: Diagnostic criteria and outcome measurement of amyotrophic lateral sclerosis Advances in Neurology 88: 53-62
Horstmann, P. 1974: Determination of serum creatine phosphokinase activity as an aid in the clarification of attacks Der Nervenarzt 45(8): 445-446
Mamoli, B. 1996: Medical intensive care aspects in treatment of amyotrophic lateral sclerosis Wiener Medizinische Wochenschrift 146(9-10): 188-190
Epstein, Y. 1995: Clinical significance of serum creatine phosphokinase activity levels following exercise Israel Journal of Medical Sciences 31(11): 698-699
Carpenter, R.J. 1980: The primary head and neck manifestations of myasthenia gravis and amyotrophic lateral sclerosis: a diagnostic aid Connecticut Medicine 44(5): 284-286
Musaeva, L. S.; Gannyshkina, I.V.; Zavalishin, I.A.; Markova, E.D.; Ivanova-Smolenskaia, I.A. 2002: Regularities of fixation of brain serum antibodies from patients with lateral amyotrophic sclerosis in rabbit CNS Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 10-14
Shanina, N.A.; Sveĭkata, A.P.; Zavalishin, I.A.; Gel'fand, V.I. 1993: Analysis of serum antibodies to nerve tissue antigens in patients with lateral amyotrophic sclerosis Biulleten' Eksperimental'noi Biologii i Meditsiny 115(2): 169-173
Sidell, F.R.; Culver, D.L.; Kaminskis, A. 1974: Serum creatine phosphokinase activity after intramuscular injection. the effect of dose, concentration, and volume JAMA 229(14): 1894-1897
Gloor, H.O.; Vorburger, C.; Schädelin, J. 1977: Intramuscular injections and activity of serum creatine phosphokinase. Histopathological study in animal experiments Schweizerische Medizinische Wochenschrift 107(27): 948-952
Taraszkiewicz, F. 1973: Activity of creatine phosphokinase and its isoenzymes in serum of children with acute infectious diseases with particular reference to measles Polski Tygodnik Lekarski 28(43): 1699-1701
Schaposnik, F.; Salvioli, M.V.; Laguens, R.; Neuman, M.; Cacciatore, J. 1970: Creatine phosphokinase as an indication of muscular damage Revista Clinica Espanola 116(1): 29-32
Spooren, W.P.; Hengerer, B. 2000: DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis Cellular and Molecular Biology 46(1): 63-69
Giroud, M.; Varloteaux, B.; Chanderis, C.; Pechinot, A.; Michiels, Y.; Alison, M.; Nivelon, J.L.; Jahier, J.; Caron, P. 1979: Brain creatine phosphokinase in the serum of low-birth-weight newborn infants with brain damage. Diagnostic value of its determination La Nouvelle Presse Medicale 8(44): 3669
Davydov, V.V.; Tverdokhlib, V.P.; Iakushev, V.S. 1983: Creatine phosphate content and creatine phosphokinase activity in the cardiomyocyte mitochondria in myocardial infarct in rats subjected to emotional and pain stress Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 33-36
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568